Importance of ECP in monitoring allergic respiratory inflammation

International Journal of Immunopathology and Pharmacology

Volumn 10, Issue 2 SUPPL., 1997, Pages 35-38

  Di Lorenzo, G ^a   Candore, G ^a   Colombo, A ^a   Drago, A ^a   Esposito Pellitteri, M ^a   Mansueto, P ^a   Melluso, M ^a   Morici, G ^a   Caruso, C ^a  

^a UNIVERSITY OF PALERMO   (Italy)

Author keywords

Asthma; ECP; inflammation; rhinitis

Indexed keywords

PROTEIN;

ADULT; ALLERGIC RHINITIS; ASTHMA; CLINICAL ARTICLE; CONFERENCE PAPER; DISEASE SEVERITY; EOSINOPHIL; FEMALE; GRASS POLLEN; HUMAN; INFLAMMATION; MALE; PATIENT MONITORING; POLLEN ALLERGY; PRIORITY JOURNAL; PROGNOSIS;

EID: 0030944768     PISSN: 03946320     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (19)

1. Ellis A.G. 1908. The pathological anatomy of bronchial asthma. Am. J. Med. Sci. 136:407.
2. Bousquet J., Chanez P., Lacoste J.Y. et al. 1990. Eosinophilic inflammation in asthma. M Engl. J. Med. 323:1033.
3. Griffin E., Håkansson L., Formgren H. et al. 1991. Blood eosinophil number and activity in relation to lung function in patients with asthma and with eosinophilia. J. Allergy Clin. Immunol. 87:548.
4. Desreumaux P., Capron M. 1996. Eosinophils in allergic reactions. Curr. Op. Immunol. 8:790.
5. 5.: Desreumaux P., Bloget F., Seguy D. et al. 1996. Interleukin-3, granulocyte-macrophage-colony stimulating factor and interleuchin-5 synthesis in eosinophilic gastroenteritis. Gastroenterology 110:768.
6. Venge P. 1993. Eosinophil and neutrophil granulocytes. Allergy 48:39.
7. Venge P. 1994. Soluble markers of allergic inflammation. Allergy 49:1.
8. Venge P. 1995. Monitoring of asthma inflammation by serum measurements of eosinophil cationic protein (ECP). A new clinical approach to asthma management. Respiratory Med. 89:1.
9. Venge P, Henriksen J, Dahl R. 1991. Eosinophils in exercise-induced asthma. J. Allergy Clin. Immunol. 88:699.
10. Zimmerman B., Lanner A., Enander I. et al. 1992. Total blood eosinophils, serum eosinophil cationic protein and eosinophil protein X in childhood asthma: relation to disease status and terapy. Clin. Exp. Allergy 23:564.
11. Sugai T., Sakiyama Y., Matumoto S. 1992. Eosinophil cationic protein in peripheral blood of pediatric patients with allergic diseases. Clin. Exp. Allergy 22:275.
12. Boner A.L., Peroni D.G., Piacentini G.L. et al. 1993. Influence of allergen avoidance at high altitude on serum markers of eosinophil activation in children with allergic asthma. Clin. Exp. Allergy 23:1021.
13. Juntunen-Backman K., Jarvinen P., Sorva R. 1993. Serum eosinophil cationic protein during treatment of asthma in children. J. Allergy Clin. Immunol. 92:34.
14. International Consensus Report on the diagnosis and Management of Rhinitis.1994. Allergy 49 (suppl 19): 1-34.
15. Naclerio R.M., Meier H.L., Kagey-Sobotka A. et al. 1983. Mediators release after nasal airway challenge with allergen. Am. Rev. Respir. Dis. 128:597.
16. Svensson C., Andersson M., Persson C.G. A., Venge P., Alkner U.L.F., Pipkorn U. 1990. Albumin, bradikinins, and eosinophil cationic protein on the nasal mucosal surface in patients with hay fever during natural allergen exposure. J. Allergy Clin. Immunol. 85:828.
17. Wang D., Clement P., Smitz J., De Waele M., Derde MP. 1995. Correlation between complaints, inflammatory cells and mediators concentrations in nasal secretions after nasal allergen challenge and during allergen exposure. Int. Arch. Allergy Immunol. 106:278.
18. Kuna P, Lazorovich M, Kaplan A P. 1996. Chemokines in seasonal allergic rhinitis. J. Allergy Clin. Immunol. 97:104.
19. UniCAP E.C.P. 1995. Fluoroimmunoassay Pharmacia N52-5014-64/01. Issued November Pharmacia AB, Uppsala, Sweden.